Skip to main content

Advertisement

Log in

Alleviation of podocyte injury: the possible pathway implicated in anti-inflammation of alpha-lipoic acid in type 2 diabetics

  • Original Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background and aims

The objective of this study is to observe the effect of alpha-lipoic acid (ALA) on Pod injury by anti-inflammation and explore its possible renal protective mechanism.

Methods

A total of 36 cases with type 2 diabetes with microalbuminuria and fasting plasma glucose (FPG) levels less than 9 mmol/L and glycated hemoglobin A1c (HbA1c) ≤9.0 % were recruited to be treated with ALA (600 mg, daily) for 6 months (group DA). Another 30 healthy individuals were chosen as normal controls (group NC). The levels of serum creatinine (Cr), FPG, and HbA1c were detected; blood pressure was recorded; and early morning urine samples (corrected for urinary Cr) were collected for the examination of urinary monocyte chemoattractant protein-1 (MCP-1), transforming growth factor-β1 (TGF-β1), podocalyxin (PCX), nephrin, albumin and Cr in group NC and group DA at the baseline and the sixth month.

Results

The excretions of urinary MCP-1, TGF-β1, PCX, nephrin and albumin to Cr ratio (abbreviated as UMCR, UTCR, UPCR, UNCR and UACR respectively) were significantly increased in group DA compared with group NC (all P < 0.01), and after 6-month treatment, all indexes mentioned above decreased markedly (P < 0.05), while FPG and HbA1c had no obvious changes. Additionally, there was a positive correlation between UMCR, UTCR with UPCR, UNCR and UACR, respectively (all P < 0.01).

Conclusions

Anti-inflammation of ALA in vivo and local kidney is implicated in the protection of glomerular Pod injury in patients with type 2 diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Navarro González JF, Mora Fernández C (2008) The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19(3):433–442

    Article  PubMed  Google Scholar 

  2. Wu CC, Sytwu HK, Lin YF (2012) Cytokines in diabetic nephropathy. Adv Clin Chem 56:55–74

    Article  PubMed  CAS  Google Scholar 

  3. Ibrahim S, Rashed L (2008) Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus. Saudi J Kidney Dis Transpl 19(6):911–917

    PubMed  Google Scholar 

  4. Ka SM, Yeh YC, Huang XR, Chao TK, Hung YJ, Yu CP et al (2012) Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor-κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice. Diabetologia 55(2):509–519

    Article  PubMed  CAS  Google Scholar 

  5. Lee HS (2012) Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease. Cell Tissue Res 347(1):129–140

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Okamura K, Dummer P, Kopp J, Qiu L, Levi M, Faubel S et al (2013) Endocytosis of albumin by podocytes elicits an inflammatory response and induces apoptotic cell death. PLoS ONE 8(1):e54817

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Campbell KN, Raij L, Mundel P (2011) Review role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Curr Diabetes Rev 7(1):3–7

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Mathieson PW (2009) Review update on the podocyte. Curr Opin Nephrol Hypertens 18(3):206–211

    Article  PubMed  Google Scholar 

  9. Tarabra E, Giunti S, Barutta F, Salvidio G, Burt D, Deferrari G et al (2009) Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes. Diabetes 58(9):2109–2118

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  10. Habara P, Marecková H, Sopková Z, Malícková K, Zivorová D, Zima T et al (2008) A novel method for the estimation of podocyte injury: podocalyxin-positive elements in urine. Folia Biol (Praha) 54(5):162–167

    CAS  Google Scholar 

  11. Zheng M, Lv LL, Ni J, Ni HF, Li Q, Ma KL et al (2011) Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy. PLoS ONE 6(5):e20431

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  12. Mihai B, Lăcătuşu C, Graur M, Cijevschi-Prelipcean C, Mihai C (2010) Pharmacologic therapy in peripheral diabetic polyneuropathy. Rev Med Chir Soc Med Nat Iasi 114:332–341

    PubMed  CAS  Google Scholar 

  13. Yi X, Nickeleit V, James LR, Maeda N (2011) α-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy. J Diabetes Complicat 25(3):193–201

    Article  PubMed  PubMed Central  Google Scholar 

  14. Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB, Thomas DB et al (2008) The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 14(3):290–298

    Article  PubMed  CAS  Google Scholar 

  15. Yu L, Lin Q, Feng J, Dong X, Chen W, Liu Q et al (2013) Inhibition of nephrin activation by c-mip through Csk-Cbp-Fyn axis plays a critical role in Angiotensin II-induced podocyte damage. Cell Signal 25(3):581–588

    Article  PubMed  CAS  Google Scholar 

  16. Kobayashi T, Notoya M, Shinosaki T, Kurihara H (2009) Cortactin interacts with podocalyxin and mediates morphological change of podocytes through its phosphorylation. Nephron Exp Nephrol 113(3):e89–e96

    Article  PubMed  CAS  Google Scholar 

  17. Keith Dove J, Butler Judy A, Bemer Brett, Dixon Brian, Johnson Shawn, Garrard Mary et al (2012) Age and gender dependent bioavailability of R- and R, S-α-lipoic acid: a pilot study. Pharmacol Res 66:199–206

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  18. Tesch GH (2008) MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 294(4):F697–F701

    Article  PubMed  CAS  Google Scholar 

  19. Winiarska K, Malinska D, Szymanski K, Dudziak M, Bryla J (2008) Lipoic acid ameliorates oxidative stress and renal injury in alloxan diabetic rabbits. Biochimie 90:450–459

    Article  PubMed  CAS  Google Scholar 

  20. Kang KP, Kim DH, Jung YJ, Lee AS, Lee S, Lee SY et al (2009) Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation. Nephrol Dial Transplant 24(10):3012–3020

    Article  PubMed  CAS  Google Scholar 

  21. Lee EY, Chung CH, Khoury CC, Yeo TK, Pyagay PE, Wang A et al (2009) The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability. Am J Physiol Renal Physiol 297(1):F85–F94

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  22. Hohenstein B, Daniel C, Hausknecht B, Boehmer K, Riess R, Amann KU et al (2008) Correlation of enhanced thrombospondin-1 expression, TGF-beta signalling and proteinuria in human type-2 diabeticnephropathy. Nephrol Dial Transplant 23(12):3880–3887

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  23. Lee HS, Song CY (2010) TGF-beta on podocytegrowth and disease progression in proliferativepodocytopathies. Kidney Blood Press Res 33(1):24–29

    Article  PubMed  CAS  Google Scholar 

  24. López-Hernández FJ, López-Novoa JM (2012) Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res 347(1):141–154

    Article  PubMed  Google Scholar 

  25. Nam BY, Paeng J, do Kim SH, Lee SH, Kim H, Kang HY et al (2012) MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions. Apoptosis 17(1):1–13

    Article  PubMed  CAS  Google Scholar 

  26. Eyre J, Burton JO, Saleem MA, Mathieson PW, Topham PS, Brunskill NJ (2011) Monocyte- and endothelial-derived microparticles induce an inflammatory phenotype in human podocytes. Nephron Exp Nephrol 119(3):e58–e66

    Article  PubMed  CAS  Google Scholar 

  27. Andreasen AS, Kelly M, Berg RM, MØller K, Pedersen BK (2011) Type 2 diabetes is associated with altered NF-κB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS. PLoS ONE 6(9):e23999

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  28. Ohga S, Shikata K, Yozai K, Okada S, Ogawa D, Usui H et al (2007) Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-B activation. Am J Physiol Renal Physiol 292(4):F1141–F1150

    Article  PubMed  CAS  Google Scholar 

  29. Gorąca A, Huk Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B (2011) Lipoic acid—biological activity and therapeutic potential. Pharmacol Rep 63(4):849–858

    Article  PubMed  Google Scholar 

  30. Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB, Thomas DB et al (2008) The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 14(3):290–298

    Google Scholar 

  31. Fiorentino L, Cavalera M, Menini S, Marchetti V, Mavilio M, Fabrizi M et al (2013) Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay. EMBO Mol Med 5(3):441–455

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  32. Bollee G, Flamant M, Schordan S, Fligny C, Rumpel E, Milon M et al (2011) Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. 17:1242–1250

    CAS  Google Scholar 

  33. Uchigata Yasuko, Hirata Yukimasa, Iwamoto Yasuhiko (2010) Insulin autoimmune syndrome (Hirata disease): epidemiology in Asia, including Japan. Diabetol Int 1:21–25

    Article  Google Scholar 

  34. Furukawa N, Miyamura N, Nishida K, Motoshima H, Taketa K, Araki E (2007) Possible relevance of alpha lipoic acid contained in a health supplement in a case of insulin autoimmune syndrome. Diabetes Res Clin Pract 75:366–367

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by the natural science foundation (No. 11040606M159) and natural science research project (No. KJ2011A157) of Anhui Province of China. Great help was offered by the Department of Endocrinology of Anhui Provincial Hospital affiliated to Anhui Medical University of China.

Conflict of interest

The authors state that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shan-Dong Ye.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bao, XH., Xu, J., Chen, Y. et al. Alleviation of podocyte injury: the possible pathway implicated in anti-inflammation of alpha-lipoic acid in type 2 diabetics. Aging Clin Exp Res 26, 483–489 (2014). https://doi.org/10.1007/s40520-014-0207-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-014-0207-1

Keywords

Navigation